Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid

Scand J Infect Dis. 2008;40(1):67-73. doi: 10.1080/00365540701509915. Epub 2007 Jul 27.

Abstract

Linezolid is not yet recognized as a standard therapy for infective endocarditis but its use becomes a necessity when infection is due to multidrug-resistant microorganisms. This report describes 1 patient with endocarditis treated with linezolid and 45 similar cases from the medical literature.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acetamides / therapeutic use*
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Endocarditis, Bacterial / drug therapy*
  • Humans
  • Linezolid
  • Male
  • Methicillin Resistance / drug effects*
  • Oxazolidinones / therapeutic use*
  • Prosthesis-Related Infections / drug therapy
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / pathogenicity

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Linezolid